Drug Pipeline
| Company | IND | Phase I | Phase II | Phase III | FDA Approved | Product on Market | Condition / Market |
|---|---|---|---|---|---|---|---|
| Ascenta Therapeutics | AT-101 | Follicular Lymphoma; Diffuse Large Cell Lyphoma; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia | |||||
| Ascenta Therapeutics | AT-101 w/ Rituximab | Chronic Lymphocytic Leukemia | |||||
| Ascenta Therapeutics | AT-101 | AT-101 | Hormone Refractory Prostate Cancer | ||||
| Ascenta Therapeutics | AT-101 w/ Docetaxel | AT-101 w/ Docetaxel | Hormone Refractory Prostate Cancer | ||||
| Astellas | AMEVIVE | 2003 | Plaque Psoriasis | ||||
| Attenuon | ATN-224 | ||||||
| Centocor | CNT0888 | ||||||
| Genzyme | Genz 112638 | Gaucher's Disease | |||||
| GSK (Corixa) | BEXXAR | 2003 | CD20 positive, follicular, non-Hodgkin's lymphoma | ||||
| MedImmune, Inc. | FluMist: bivalent vaccine | FluMist | 2003 | Influenza Vaccine | |||
| NanoBio Corp. | NB-001 | Herpes | |||||
| NanoBio Corp. | NB-002 | Onychomycosis (nail fungus) topical treatment | |||||
| Pfizer | IDN-6556 | For hepatitis, liver damage, and liver cancer | |||||
| Vical | Allovectin-7 | Metastatic Melanoma | |||||
| ViroPharma | Maribavir VP-41263 | Cytomegalovirus (CMV); Liver transplant | |||||
| Xcyte Therapies / Invitrogen | Xcellerated T Cells | Non-Hodgkin's Lymphoma |
Printed from: http://www.techtransfer.umich.edu/news_events/drug_pipeline.php